3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
2
Thrombosis
1
Thrombophilia
1
Thrombocytopenia
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma
1
Leukopenia
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Hypersplenism
1
Hemoglobinuria, Paroxysmal
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Antiphospholipid Syndrome
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
fludarabine phosphate
6
Whole-Body Irradiation
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Tacrolimus
3
Mycophenolic Acid
3
Methotrexate
3
Busulfan
3
thymoglobulin
2
Cyclosporine
2
Cyclophosphamide
2
Antilymphocyte Serum
2
Alemtuzumab
2
treosulfan
1
sargramostim
1
ravulizumab
1
merphos
1
bryostatin 1
1
X-Rays
1
Transplantation, Homologous
1
Sirolimus
1
Observation
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Etoposide
1
Cyclosporins
1
Bryostatins
1
Bone Marrow Transplantation
1
Basiliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemoglobinuria, Paroxysmal
×
Observation
×
Classical hematology
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled